Clinical Trials in Ibadan, Oyo State
12 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled105 locationsNCT06609226
Recruiting
Not Applicable
Change My Story Task Shifted Mental Health Intervention
Psychological DistressDepressionHIV
Massachusetts General Hospital80 enrolled1 locationNCT06389565
Recruiting
Phase 2
MicroRNA Profiles in Triple Negative Breast Cancer
Triple-Negative Breast Cancer
University College Hospital, Ibadan42 enrolled4 locationsNCT04771871
Recruiting
Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Novo Nordisk A/S408 enrolled172 locationsNCT06612268
Recruiting
Phase 2
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Triple-Negative Breast Cancer
University of Chicago85 enrolled4 locationsNCT06291064
Recruiting
Phase 2
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Breast CancerHER2-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
University of Chicago74 enrolled4 locationsNCT06348134
Recruiting
Phase 1
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Pediatric HIV InfectionTuberculosis Infection
Brigham and Women's Hospital20 enrolled1 locationNCT05069688
Recruiting
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Breast CancerBreast Cancer Female
Memorial Sloan Kettering Cancer Center900 enrolled8 locationsNCT05561842
Recruiting
Phase 2
ATORvastatin in Pulmonary TUBerculosis
TuberculosisPulmonary TuberculosisKoch's Disease
Obafemi Awolowo University Teaching Hospital440 enrolled8 locationsNCT06199921
Recruiting
Phase 1
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Pediatric HIV InfectionLatent Tuberculosis
Brigham and Women's Hospital25 enrolled1 locationNCT06281834
Recruiting
Early Phase 1
Evaluating the Impact of Demand-Side Incentives (DSI) on Zero Dose Burden and Immunisation Coverage in Nigeria
Incentives
Corona Management Systems100,000 enrolled2 locationsNCT06676787
Recruiting
The Ibadan Acute and Chronic Heart Failure Project
Heart Failure
University College Hospital, Ibadan2,000 enrolled1 locationNCT05936957